Classification
- Anatomical main groupLAntineoplastic and immunomodulating agents
- Therapeutic subgroupL04
- Pharmacological subgroupL04A
- Chemical subgroupL04AASelective immunosuppressants
- Chemical substanceL04AA60Remibrutinib
Where it is registered
Each register and historical list with its number of registrations and a few of them.
Canada
Health Canada · 1 registration
Spain
AEMPS · 1 registration
European Union
EMA · 1 registration
Croatia
HALMED · 1 registration
Netherlands
CBG-MEB · 1 registration
At a glance
- ATC code
- L04AA60
- Registers
- 6
- Registrations
- 6
- With their own page
- 6
- Companies
- 3
All medicines with Remibrutinib
Human medicines from every register that match Remibrutinib by substance or by name, a page at a time, so the count can differ from the registrations above. Strengths and packs are on each medicine’s page.
8 search results
| Medicine | Register | Strength | Form | Status | Holder |
|---|---|---|---|---|---|
| Rhapsido | United States | 25MG | tablet | Marketed | Novartis |
| Rhapsido | European Union | Authorised | Novartis Europharm Limited | ||
| Rhapsido 25 MG Comprimidos Recubiertos con Pelicula | Spain | 25 mg | comprimido recubierto con película | Authorised | Novartis Europharm Limited |
| Rhapsido 25 mg filmomhulde tabletten | Netherlands | Filmomhulde tablet | Authorised | Novartis Europharm Limited | |
| Rhapsido | Canada | 25 MG | Tablet | Authorised | Novartis Pharmaceuticals Canada INC |
| Rhapsido | Croatia | Authorised | |||
| Ibrutinib | United States | 140MG, 70MG | capsule | Tentative approval | Teva Pharms USA INC |
| Ibrutinib | United States | 140MG, 280MG, 420MG … | tablet | Tentative approval | Alvogen Pine Brook |